TherapeuticsMD (NASDAQ:TXMD) reported its Q2 earnings results on Monday, August 15, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
TherapeuticsMD missed estimated earnings by 13.16%, reporting an EPS of $-3.44 versus an estimate of $-3.04.
Revenue was up $5.56 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.72 which was followed by a 14.01% drop in the share price the next day.
Here's a look at TherapeuticsMD's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -4 | -4 | -5 | -5.5 |
| EPS Actual | -4.72 | -4.5 | -5.5 | -5.5 |
| Revenue Estimate | 17.95M | 29.39M | 25.87M | 22.11M |
| Revenue Actual | 19.33M | 18.68M | 25.41M | 23.00M |
To track all earnings releases for TherapeuticsMD visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
